1. A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia. Issue 4 (5th August 2019) Authors: Visentin, Andrea; Deodato, Marina; Mauro, Francesca R.; Autore, Francesco; Reda, Gianluigi; Vitale, Candida; Molica, Stefano; Rigolin, Gian Matteo; Piazza, Francesco; Cesini, Laura; Tedeschi, Alessandra; Laurenti, Luca; Cassin, Ramona; Coscia, Marta; Cuneo, Antonio; Foà, Robin; Semenzato, Gianpie... Journal: Hematological oncology Issue: Volume 37:Issue 4(2019) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Issue 5 (24th February 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Da... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: E168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience. Issue 10 (2nd October 2016) Authors: Laurenti, Luca; Autore, Francesco; Innocenti, Idanna; D'Arena, Giovanni; Coscia, Marta; Mondello, Patrizia; Chiusolo, Patrizia; Bellesi, Silvia; Efremov, Dimitar G.; Sica, Simona; Mauro, Francesca Romana Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia. Issue 6 (22nd November 2022) Authors: Perutelli, Francesca; Montalbano, Maria Chiara; Boccellato, Elia; Coscia, Marta; Vitale, Candida Journal: Current opinion in oncology Issue: Volume 34:Issue 6(2022) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results. (August 2019) Authors: D'Arena, Giovanni; Valvano, Luciana; Vitale, Candida; Coscia, Marta; Statuto, Teodora; Bellesi, Silvia; Lamorte, Daniela; Musto, Pellegrino; Laurenti, Luca; D'Auria, Fiorella Journal: Leukemia research Issue: Volume 83(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CD200 included in a 4‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia. Issue 3 (30th March 2018) Authors: D'Arena, Giovanni; Vitale, Candida; Rossi, Giovanni; Coscia, Marta; Omedè, Paola; D'Auria, Fiorella; Statuto, Teodora; Valvano, Luciana; Ciolli, Stefania; Gilestro, Milena; Molica, Stefano; Bellesi, Silvia; Topini, Giuseppe; Panichi, Valentina; Autore, Francesco; Innocenti, Idanna; Musto, Pellegr... Journal: Hematological oncology Issue: Volume 36:Issue 3(2018) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia. (October 2022) Authors: Frustaci, Anna Maria; Del Poeta, Giovanni; Visentin, Andrea; Sportoletti, Paolo; Fresa, Alberto; Vitale, Candida; Murru, Roberta; Chiarenza, Annalisa; Sanna, Alessandro; Mauro, Francesca Romana; Reda, Gianluigi; Gentile, Massimo; Varettoni, Marzia; Baratè, Claudia; Borella, Chiara; Greco, Antonin... Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials. (June 2016) Authors: Gentile, Massimo; Zirlik, Katja; Ciolli, Stefania; Mauro, Francesca R.; Di Renzo, Nicola; Mastrullo, Lucia; Angrilli, Francesco; Molica, Stefano; Tripepi, Giovanni; Giordano, Annamaria; Di Raimondo, Francesco; Selleri, Carmine; Coscia, Marta; Musso, Maurizio; Orsucci, Lorella; Mannina, Donato; Ra... Journal: European journal of cancer Issue: Volume 60(2016) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases. (28th January 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo... Journal: European journal of haematology Issue: Volume 106:Number 4(2021) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey. Issue 4 (April 2014) Authors: D'Arena, Giovanni; Laurenti, Luca; Coscia, Marta; Cortelezzi, Agostino; Chiarenza, Annalisa; Pozzato, Gabriele; Vigliotti, Maria Luigia; Nunziata, Giuseppe; Fragasso, Alberto; Villa, Maria Rosaria; Grossi, Alberto; Selleri, Carmine; Deaglio, Silvia; La Sala, Antonio; Del Poeta, Giovanni; Simeon, ... Journal: Leukemia & lymphoma Issue: Volume 55:Issue 4(2014:Apr.) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗